Report - Osimertinib as adjuvant therapy in patients with stage IB ......Herbst 1.0 0.8 0.2 0.0 115 stage IllA Time from randomization (months) #ASC020 PRESENTED Roy S. Early snapshot: overall

Select PornographicDefamatoryIllegal/UnlawfulSpamOther Terms Of Service ViolationFile a copyright complaint

Please pass captcha verification before submit form